FDA Adverse Event Malfunction Summary report: N

COBAS 6000 C501 MODULE

MDR report key: 20631344 · Received November 7, 2024

Report

Report Number
1823260-2024-03216
Event Type
Malfunction
Date Received
November 7, 2024
Date of Event
October 11, 2024
Report Date
December 19, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
04015630924707
PMA / PMN Number
K060373
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SF
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE REAGENT LOT NUMBER IS 801081. THE EXPIRATION DATE WAS NOT PROVIDED. THE FIELD SERVICE ENGINEER (FSE) OBSERVED TRACES OF SAMPLE TUBE SEPARATOR GEL WAS FOUND ON THE SAMPLE PROBE AND A KNICK IN THE TUBING FROM THE PRESSURE SENSOR TO THE SAMPLE SYRINGE. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE INVESTIGATION DETERMINED THE ISSUE WAS DUE TO PRE-ANALYTICAL HANDLING ISSUES AT THE CUSTOMER SITE. CORRECT PRE-ANALYTIC SAMPLE HANDLING IS WITHIN THE CUSTOMER'S RESPONSIBILITY. THERE IS NO EVIDENCE TO SUGGEST A MALFUNCTION OF THE DEVICE.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE CREP2 CREATININE PLUS VER.2 RESULTS FOR 3 PATIENT SERUM SAMPLE ON A COBAS 6000 C501 MODULE. ON (B)(6) 2024, SAMPLE 1 HAD AN INITIAL RESULT OF 258 UMOL/L WITH FLAG. ON (B)(6) 2024, THE SAMPLE WAS REPEATED TWICE AND THE RESULTS WERE 62 UMOL/L AND 66 UMOL/L. ON (B)(6) 2024, SAMPLE 2 HAD AN INITIAL RESULT OF 509 UMOL/L AND A REPEAT RESULT OF 116 UMOL/L. ON (B)(6) 2024, SAMPLE 3 INITIAL RESULT OF 649 UMOL/L AND A REPEAT RESULT OF 55 UMOL/L. THE REPEAT RESULTS WERE DEEMED CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1625394 COBAS 6000 C501 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 04015630924707

Patients

Seq Age Sex Outcome Treatment
1 44 YR Female